Back to 
FRONTIER CAPITAL MANAGEMENT CO LLC
FRONTIER CAPITAL MANAGEMENT CO LLC
RARE4 quarters
Position history for FRONTIER CAPITAL MANAGEMENT CO LLC's holdings in ULTRAGENYX PHARMACEUTICAL IN
FRONTIER CAPITAL MANAGEMENT CO LLC holds 2.2M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $45.9M as of 2026-Q1. The position was increased (+11.5% shares). RARE represents 0.5% of FRONTIER CAPITAL MANAGEMENT CO LLC's portfolio.
Current Value
$45.9M
Current Shares
2.2M
Total Value Change
+$26.8M
Total Shares Change
+1.7M
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.